Note: Not all studies are available based on copyrights of the original documents. Please note the PARI Pharma copyright studies are owned by PARI Pharma. Data may not be referenced in any way including print and electronic formats without the prior written consent of PARI Pharma.

M. Knoch, W. Finlay: Nebulizer Technologies Source: Drugs and the Pharmaceutical Sciences; Volume 126; „Modified-Release Drug Delivery Technology“; edited by M. J: Rathbone, J. Hadgraft, M. S. Roberts; Marcel Dekker Inc.; Page 849-856;
[DDL 12-02 017] U. Schuschnig, M. Keller, F.-C. Lintz, M. Hug, A. Pfichner, M. Borgschulte, M. Knoch: Customisation of the eFlow™ Electronic Inhaler to Target Pulmonary Delivery of Aztreonam Formulations for the Treatment of Lung Infections. DDL XIII, London, December 12-13, 2002 (poster). Proceedings pp. 252-256.
[DDL 12-02 016] J. Jauernig, M. Hug, M. Knoch, M. Keller: Contribution to the aerodynamic particle size assessment of nebulised drugs using the New Generation Impactor (NGI). DDL XIII, London, December 12-13, 2002 (oral presentation). Proceedings pp. 44-47.
[DDL 12-02 015] M. Keller, U. Schuschnig, A. Balcke, R. Waldner, M. Knoch: Salbutamol nebulisation performance of eFlow™ versus air-jet nebulisers. DDL XIII, London, December 12-13, 2002 (poster). Proceedings pp. 160-164.
[DDL 12-02 014] M. Borgschulte, D. Jahn, D. Häuser, R. Stangl: The Use of Sensors in Inhalation Systems. DDL XIII, London, December 12-13, 2002 (poster). Proceedings pp. 95-98.
[ISAM 12-02 013] M. Knoch, J. Jauernig: Testing of Pharmaceutical Aerosols Generated by Nebulizers: Relevant Definitions and Methods. ISAM Symposium (Tagung der Arbeitsgemeinschaft der medikamentösen Inhalationstherapie). Tokio, Japan, December 7, 2002 (oral presentation).
[DATS 11-02 012] R. Stangl, S. Seemann, U. Schuschnig, M. Hug, R. Waldner: In-Vitro Charakterisierung des PARI e-FlowTM IMP Inhalers. VII. Deutsches Aerosol Therapie Seminar, Kassel, November 8-9, 2002, (Poster presentation).
[AAPS 11-02 011] F.-C. Lintz, S. von Opolski, M. Keller: Evaluation of a one-step granulation and neutralization process. AAPS Annual Meeting, Toronto (Canada), November 10-14, 2002, (poster presentation No. W5369). [AAPS 11-02 010] J. M. Bultmann, F.-C. Lintz: Comparison of Databases and Expert-Systems for nebulizer formulation development. AAPS Annual Meeting, Toronto (Canada), November 10-14, 2002, (poster presentation No. T2308).
[RDD 05-02 009] M. Keller, J. Jauernig, F.-C. Lintz, M. Knoch: Nebulizer Nanosuspensions: Important Device and Formulation Interactions. RDD VIII, Tucson (Arizona), May 12-16, 2002, (oral presentation). Proceedings pp. 197-206.
[RDD 05-02 008] J. Jauernig, U. Schuschnig, M. Hug, M. Keller: Validation of a test setup utilizing the 28.3 l/min Andersen Cascade Impactor (ACI) for the aerodynamic assessment of nebulized aqueous formulations. RDD VIII, Tucson (Arizona), May 12-16, 2002, (poster presentation). Proceedings pp. 537-540.
[RDD 05-02 007] F.-C. Lintz, E. Walther, M. Keller: Use of a Knowledge Based System (KBS) to shorten and streamline development of nebulizer formulations. RDD VIII, Tucson (Arizona), May 12-16, 2002, (poster presentation). Proceedings pp. 541-544.
[ATS 05-02 006] M. Keller, A. Balcke, U. Schuschnig, P. Stempfle, D. Jahn: Respirable Drug Delivery Rate (RDDR) - An Objective Parameter to Assess The Efficiency Of Nebulizers. 98th International Conference of the American Thoracic Society, Atlanta, May 17-22, 2002, (poster presentation).
[APV 04-02 005] F.-C. Lintz, M. Keller, E. Walther: Enhancement of nebuliser performance by formulation optimisation. 4th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Florence, April 8-11, 2002, (abstract).
[APV 04-02 004] F.-C. Lintz, J. M. Bultmann: Use of the self-learning expert system „AXS“ for the optimisation of nebuliser formulations. 4th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Florence, April 8-11, 2002, (poster presentation).
[APV 04-02 003] J. M. Bultmann, S. Schmitt, F.-C. Lintz: Use of the self-learning expert system „AXS“ in roller compaction troubleshooting. 4th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Florence, April 8-11, 2002, (abstract).
[DGP 03-02 002] M. Keller, R. Ledermüller, A. Balcke: Respirable Drug Delivery Rate -ein objektiver Parameter zur Bestimmung der Effizienz von Verneblersystemen. 43.Kongress der Deutschen Gesellschaft für Pneumologie (DGP), Bochum, 13. - 16. März 2002, (poster presentation, No. 127). Pneumologie 2002, Jahrg. 56, S1, p. 78.
[VAL 01-02 001] M. Keller: Novel Formulations For Inhalation - Interactions, Challenges And Limitations To Deliver Drugy By Nebulisers. Conference organised by Valois: Practical Approaches to Nasal and Pulmonary Drug Delivery, Paris, January 24-25, 2002, (oral presentation).